The FCF Healthcare & Life Sciences Venture Capital Monitor – Europe is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies, displaying Venture capital financing trends in the European Healthcare & Life Sciences industry.
As of the end of March 2024 we identify the following current VC trends in Europe:
- Total Healthcare & Life Sciences funding reached EUR 1,962m
- Biotech received 60% of the total investment volume (EUR 1,172m) with oncology being the leading indication (53%)
- In March Tubulis (Germany) secures the highest transaction volume with EUR 128m, followed by Nouscom (Switzerland) with EUR 76m and Mission Therapeutics (United Kingdom) with EUR 51m
- M&G Investments (United Kingdom) is the most active investor (by deal volume), followed by Patient Square Capital (United States) and Rock Springs Capital (United States)
Capital Markets Research
We constantly engage in capital markets research to identify financing trends early in the Life Sciences sector. Our research focuses on the most relevant equity markets: Venture Capital, Public Equity, Initial Public Offerings (IPO). The findings are currently published in the following publications:
Venture Capital
Licensing
Healthcare & Life Sciences Venture Capital Monitor – Europe
Monthly Venture capital activities in the European Life Sciences sector
Healthcare & Life Sciences Venture Capital Monitor – USAMonthly Venture capital activities in the US Life Sciences sector
Life Sciences Venture Capital ReportRecent Venture capital trends in the European Life Sciences sector
Other Research
Life Sciences IPO ReportRecent IPO trends in the Life Sciences sector
Biotech Public Equity MonitorRecent valuations of listed European Life Sciences companies
MedTech & Diagnostics Public Equity MonitorRecent valuations of listed MedTech companies
Life Sciences SPAC MonitorPerformance overview of merged Life Sciences SPACs
NEWS
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 03/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 03/2024”. The Monitor is a monthly published overview of venture capital trends in the
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 03/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 03/2024”. The Monitor is a monthly published overview of venture capital trends in
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 02/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 02/2024”. The Monitor is a monthly published overview of venture capital trends in
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 01/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 01/2024”. The Monitor is a monthly published overview of venture capital trends in
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 01/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 01/2024”. The Monitor is a monthly published overview of venture capital trends in the
